Bangkok Dusit Medical Services （BDMS.US）： 2Q24 in~line： Topline growth at +7% but margins weaker YoY； Buy

13 August 2024 | 9:54PM SGT Bangkok Dusit Medical Services (BDMS.BK); 2024 in-line: Topline growth at +7% but margins weaker YoY; Buy BDMS's 2Q24 EPS of Bt0.21 was +9% YoY and in line with GSe/IBES forecasts. Revenue growth of +7% YoY was healthy, with Thai patient contribution +5% YoY and international patients +11 % YoY, in line with earlier guidance. However, EBITDA margin of 22.1% in 2024 was weaker YoY, with 6M24 of 23.6% below full-year guidance of 24-25% and our 25% forecast, which we believe is part ...